In March 2025, the company announced new strategies for a direct-to-customer featuring of its Wegovy weight loss drug. The company established a whole new pharmacy, identified as NovoCare, which would demand customers $499 per 30 days for usage of the drug, lower than half the expense of the drug by other pharmaceutical distribution networks.[53]Sc